Assessing cardiometabolic parameter monitoring in inpatients taking a second-generation antipsychotic: The CAMI-SGA study - a cross-sectional study.

ABSTRACT:

Objectives

This study aims to determine the proportion of initial cardiometabolic assessment and its predicting factors in adults with schizophrenia, bipolar disorder or other related diagnoses for whom a second-generation antipsychotic was prescribed in the hospital setting.

Design

Cross-sectional study.

Setting

The psychiatry unit of a Canadian tertiary care teaching hospital in Montreal, Canada.

Participants

402 patients with aforementioned disorders who initiated, restarted or switched to one of the following antipsychotics: clozapine, olanzapine, risperidone, paliperidone or quetiapine, between 2013 and 2016.

Primary outcome measures

We assessed the proportion of cardiometabolic parameters monitored.

Secondary outcome measures

We identified p

SUBMITTER: Fontaine J 

PROVIDER: S-EPMC9006820 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature